Navigation Links
ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Date:5/7/2009

- Updates guidance regarding strategic transaction process

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced results from its bioequivalence study of ANX-514 (docetaxel emulsion). ANX-514 was determined to have comparable overall safety as Taxotere(R), the reference product, with no differences between treatment groups in severe toxicities. However, pharmacokinetic equivalence, the primary endpoint of the study, was not demonstrated based on benchmark regulatory standards.

"Following discussions with clinicians and experts in taxane pharmacokinetics, we believe that the increased blood-levels of docetaxel, which we observed solely during the first hour of a 168-hour observation period, do not affect the safety or efficacy of the drug and are not clinically relevant, and that our pharmacokinetic data should be sufficient to support an NDA for ANX-514," said Brian M. Culley, Chief Business Officer of ADVENTRX. "In addition, we have not fully investigated whether variability with respect to study drug administration and/or blood sample collection may have affected the results. However, the FDA is the final arbiter of safety and efficacy and, following discussion with the Agency, we will have more insight into whether additional pre-clinical and/or clinical activities may be necessary before submitting an NDA for ANX-514."

"The possibility of additional activities creates uncertainty around the cost and timeline to FDA approval of ANX-514, which may adversely impact our on-going strategic transaction discussions," Mr. Culley continued. "Consequently, and in light of our current working capital, we are evaluating both our strategic and non-strategic options."

The study data revealed higher blood-levels of docetaxel during and immediate
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
2. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
3. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
4. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
5. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
8. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
9. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
10. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... WELWYN GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, ... Akira Usui as a Consultant to augment the Company,s ... Asian territories. Mr Usui has more than 15 years ... pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... recently published clinical study conducted at TOPS Comprehensive Breast ... that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls ... study, "Implementation of Breast Tomosynthesis in a Routine Screening ... Stephen L. Rose , MD, and published in ... Roentgenology (AJR). The AJR is the scientific journal ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... MINNEAPOLIS, Jan. 29 AGA Medical Corporation today launched ... Bruschi, a professional football player who suffered a stroke ... career. The unique online educational program will consist of ... Medical website that describe Tedy,s firsthand experience as a ...
... Jan. 28 Today at the American Academy of ... California at,San Diego report that no standardized practices ... Researchers looked at many factors,including: which steroids were ... a local anesthetic was mixed with the steroid. , ...
Cached Medicine Technology:AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 2AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 3Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain 2
(Date:5/25/2013)... (PRWEB) May 25, 2013 An experienced ... page in partnership with JD Media Surge, LLC. ... are now available and, depending on the treatment, can ... a routine visit, the best method will be chosen ... performed during a visit. A special peroxide-based whitening gel ...
(Date:5/25/2013)... News) -- Many viruses and parasites that affect both ... a bacteria-borne illness than can result in liver or ... according to a veterinarian. These germs could ... air, said Dr. Susan Nelson, a clinical associate professor ... these serious diseases can be fatal, even with treatment," ...
(Date:5/25/2013)... Providing patients with their best weight loss is ... management professionals. But, aside from educating patients on how to ... hCG diets also provide patients, who have gained weight ... more control over their lives by achieving their best weight ... factors of weight gain derived from earlier abuse, Diet Doc's ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 By working ... officially declared the integration of the 2012 Lamborghini Aventador ... is the latest entrant in the list of vehicles ... the vehicle is all set to thrill automobile lovers ... acceleration power and spectacular looks, the 2012 Lamborghini Aventador ...
(Date:5/25/2013)... May 25, 2013 According to world-renowned ... beautiful and powerful women that ever lived. Cleopatra’s legendary ... some of the most powerful men in her time. ... remedies to keep her skin glowing and fresh, from ... bees- wax, maringa oil and cyprus grass. , Cleopatra ...
Breaking Medicine News(10 mins):Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
... Royer Animal Health, LLC, a wholly owned subsidiary ... agreement with MWI Veterinary, Supply, Inc. (Nasdaq: ... MATRIX III CISPLATIN BEADS and R-GEL ... products provide veterinary professionals with localized treatment options for ...
... of protests in Washington urging inclusion of the Community ... Impact points to the success of existing community-based, affordable ... number of those who need more intense health care ... million people with disabilities in the U.S., there is ...
... SCOTT DEPOT, W.Va., April 30 International Coal Group, Inc. (NYSE: ... the lead Pink Ribbon sponsor for the 2009 Susan G. Komen ... is scheduled to start at 9 a.m. in front of the ... honors the late Susan G. Komen, who died of breast cancer ...
... 30 SynCare, LLC, today announced it was awarded ... HealthCare USA members in Missouri. HealthCare USA engaged SynCare ... membership into appropriate case management programs.HealthCare USA is a ... Medicaid and SCHIP members. Their mission is to improve ...
... The Providence Service Corporation (Nasdaq: PRSC ... results for its first quarter ended March 31, 2009 on ... a conference call at 11:00 a.m. EDT (9:00 a.m. MDT ... to discuss its financial results and corporate developments. Interested ...
... McEntee praises Obama request for $1.5 billion in additional ... union survey of more than 100 health care facilities ... prepared to protect workers, health and safety during an ... In Peril: Preparing to Protect Worker Health and Safety ...
Cached Medicine News:Health News:Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections 2Health News:Community Approach Necessary For Affordable Long-Term Care, Says NCB Capital Impact 2Health News:SynCare, LLC(TM) Awarded HealthCare USA Health Risk Assessments Contract 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 3Health News:Union Survey on Influenza Pandemic Finds Lack of Adequate Health and Safety Measures for Health Care Workers 2Health News:Union Survey on Influenza Pandemic Finds Lack of Adequate Health and Safety Measures for Health Care Workers 3
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
The SURGIWIP™ suture ligature with delivery system is indicated for use in gynecologic, general and other abdominal and thoracic endoscopic procedures where a suture is appropriate for the endo...
Surgitie&trade Single Use Ligating Loops without Delivery System with POLYSORB™....
Medicine Products: